Sylvie Leotin
Transdisciplinary Scholar. Innovator. Keynote Speaker
Sylvie Leotin had every reason to lose trust in medicine after her cancer care experience. Instead, she set out to understand a troubling paradox: How could medicine meet rigorous standards and still leave patients exposed to risks it did not recognize? That inquiry grew into $1.75 million in funded medical research, which she led as Principal Investigator—a role typically held by physicians and scientists who have spent their careers in academia. A transdisciplinary scholar and innovator, she brings expertise in systems thinking, robotics, engineering, and technology, insight into human vulnerability, and decades of human-centered innovation to healthcare. Her research points to the next frontier for human care.
A Transdisciplinary Scholar
The journey that led her to pursue that question was unusual. Trained professionally in ballet at France’s National Conservatory, she learned to sense how a system behaves from within—through the direct experience of her body. As an early researcher at the Stanford Robotics Laboratory, she absorbed a principle that stayed with her: a machine can only act on what it can perceive. A Stanford master’s in Engineering Economic Systems gave her the tools to analyze the human consequences of complex systems. She then spent decades in technology innovation, working at global technology giants and early-stage companies before founding her own innovation practice, where she pioneered an immersive method for revealing the blind spots between what customers experience and what the companies building for them see.
Grant-Funded Researcher
She brought that approach into medical research as an independent Principal Investigator and Founder of Equify Health. Partnering with Emory University School of Medicine, she secured a $750,000 Genentech grant to investigate blind spots in patient care, then translated the findings into an immersive workshop that helped clinicians discover risks they had not previously recognized. Its success led to a second $1 million Genentech grant, bringing total funding to $1.75 million.
Her research uncovered the underlying structural cause of these blind spots and laid the foundation for a new conceptual framework that challenges how medicine defines safety. Today, her work brings together medicine, technology, systems, ethics, and society to reveal risks before they are built into the future of care.
“Few people bridge technology, human-centered design, systems thinking, and healthcare research as Sylvie does. Her work revealing risks that remain invisible to health systems is trailblazing, with real implications for patient safety, trust, equity, and AI.”
— Douglas Slakey, MD, Chair of Health Systems Science, Thomas F. Frist, Jr. College of Medicine
“Sylvie Leotin is a talented storyteller, a wise woman and a visionary regarding the ills of our healthcare system and how to fix it. If we are ever to improve the care of cancer patients, it will be by listening to voices such as hers.”
— George Sledge, MD, former President, American Society of Clinical Oncology
Healthcare Systems Innovator
Sylvie is Affiliate Faculty at Belmont University College of Medicine and a Fellow of the Belmont Collaborative for Health Systems Innovation. These roles connect her work with health system leaders and medical educators who shape how care is designed and taught. Beyond academia, she also advises an AI-powered digital health startup, bringing her perspective into the development of emerging healthcare technologies.
Sylvie has delivered keynotes and Grand Rounds for the National Cancer Institute, Stanford Medicine, Yale School of Medicine, Henry Ford Health, and national professional medical associations. She has published in the Journal of Patient Experience and STAT and has been featured in The Boston Globe and on the ASCO podcast and Follow Your Different.
Selected Speaking Engagements
Work with Sylvie
Sylvie Leotin welcomes invitations to speak, teach, advise, and collaborate on healthcare innovation, the future of human-centered care, patient safety, trust, and the ethics of AI. She brings a distinctive vantage point to the blind spots of complex human systems and what they mean for the people who depend on them. Get in touch to explore what we can accomplish together.